Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Injections for Biomarkers in Acute ACL Tears
NCT04088227Phase 2Completed
- Sponsor
- Andrews Research & Education Foundation
- Start
- Sep 2019
- Primary completion
- Sep 2022
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of autologous platelet-rich plasma in anterior cruciate ligament injury, sponsored by Andrews Research & Education Foundation. Started Sep 2019; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT04088227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088227.